Brief: Nervgen Reports Second Quarter 2026 Financial Results And Provides Business Updates
13/08/2026 13:35
BRIEF-Nervgen Reports Second Quarter 2026 Financial Results And Provides Business Updates Aug 13 (Reuters) - NervGen Pharma Corp NGEN.O:
NERVGEN REPORTS SECOND QUARTER 2026 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATES
Source text: ID:nGNX9SXjX0
Further company coverage: NGEN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nervgen Pharma
See all newsBrief: Nervgen Announces First Participant Dosed In Restore, A Phase 3 Registrational Study Evaluating NVG-291 In Chronic Spinal Cord Injury
Brief: NervGen To Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
Brief: Nervgen Reports Second Quarter 2026 Financial Results And Provides Business Updates
Brief: Nervgen Pharma Corp - Nvg-291 Shows Statistically Significant Gait Quality Improvement In Phase 1B/2A Connect Sci Study
U.S. STOCKS ON THE MOVE-Sweetgreen, Dell Technologies, Peloton Interactive